Gill Capital Partners’s Lam Research LRCX Stock Holding History

Gill Capital Partners’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.8K	Buy	205 +8	+4%	+$2.43K	0.02%	221
2026 Q1	$42.1K	Buy	+197	New	+$44K	0.01%	286

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gill Capital Partners's LRCX Position: Q2 2026 in Review

Gill Capital Partners increased its Lam Research (LRCX) stake by 4.1% in Q2 2026, buying an estimated $2.43K and bringing the position to 205 shares worth $88.8K. The position accounts for 0.02% of the portfolio, ranked #221.

Gill Capital Partners first reported a position in LRCX in Q1 2026 and has held it in 2 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Gill Capital Partners held 205 shares of Lam Research worth $88.8K as of Q2 2026.
Gill Capital Partners bought 8 Lam Research shares in Q2 2026, an estimated $2.43K.
Lam Research made up 0.02% of Gill Capital Partners's portfolio in Q2 2026, its #221 holding.
Gill Capital Partners first reported a position in Lam Research in Q1 2026 and has held it in 2 quarters since.
3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.